Lung Cancers Completed Phase 1 Trials for Etoposide (DB00773)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01579929Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)Treatment
NCT00621361Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer PatientsTreatment
NCT00006487S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung CancerTreatment
NCT00005022Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung CancerTreatment